Early-stage focus Target healthcare providers and maternal-fetal medicine groups serving families early in the pregnancy journey, emphasizing accessible and affordable NIPS solutions to expand their prenatal screening offerings.

Affordability leverage Position JunoDx as a cost-conscious option in prenatal testing to appeal to clinics and payers seeking lower-cost NIPS without compromising quality, aligning with their mission to improve access.

Strategic partnerships Pursue collaborations with obstetric clinics, hospitals, and telehealth platforms to integrate NIPS solutions into existing workflows, expanding adoption beyond a small team into broader commercial reach.

Thought leadership Utilize published NIPS methodology work and participation in industry events to build credibility with KOLs, enabling easier access to decision-makers in maternal health networks.

Funding growth Highlight the strong funding base to potential investors and customers, framing growth potential and scalability of affordable prenatal screening as a competitive differentiator in a fragmented market.